

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.32054665 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.32054665 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.83829520 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.45493462 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 4.85177938 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.74119428 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.74119428 |
| 8 | response to type I interferon (GO:0034340) | 4.68279948 |
| 9 | cellular response to type I interferon (GO:0071357) | 4.64782997 |
| 10 | type I interferon signaling pathway (GO:0060337) | 4.64782997 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.59720891 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.50765365 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.12035073 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 3.84134370 |
| 15 | detection of other organism (GO:0098543) | 3.80204767 |
| 16 | response to interferon-alpha (GO:0035455) | 3.77842904 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.73794243 |
| 18 | regulation of RIG-I signaling pathway (GO:0039535) | 3.68366420 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.65058787 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61389508 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.61389508 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61389508 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61389508 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61389508 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.61389508 |
| 26 | detection of bacterium (GO:0016045) | 3.59147526 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.53007994 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.51489415 |
| 29 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.50644918 |
| 30 | negative regulation of viral genome replication (GO:0045071) | 3.48618997 |
| 31 | positive regulation of interferon-beta production (GO:0032728) | 3.47502009 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 3.43226097 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42275387 |
| 34 | response to interferon-beta (GO:0035456) | 3.41253412 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.36669954 |
| 36 | cellular response to interferon-beta (GO:0035458) | 3.35704068 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.30835282 |
| 38 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29546470 |
| 39 | T cell migration (GO:0072678) | 3.29329554 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 3.28197844 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.26057283 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26016710 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22207184 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20791253 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20745222 |
| 46 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.19710546 |
| 47 | cellular extravasation (GO:0045123) | 3.19213060 |
| 48 | response to peptidoglycan (GO:0032494) | 3.19112653 |
| 49 | defense response to protozoan (GO:0042832) | 3.18042071 |
| 50 | regulation of tolerance induction (GO:0002643) | 3.17930656 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 3.16585557 |
| 52 | response to interleukin-15 (GO:0070672) | 3.14560140 |
| 53 | response to host (GO:0075136) | 3.11674493 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11674493 |
| 55 | cellular response to interferon-alpha (GO:0035457) | 3.11330811 |
| 56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11000092 |
| 57 | cellular response to virus (GO:0098586) | 3.10034269 |
| 58 | microglial cell activation (GO:0001774) | 3.08610865 |
| 59 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.07727539 |
| 60 | cellular response to exogenous dsRNA (GO:0071360) | 3.07599293 |
| 61 | germinal center formation (GO:0002467) | 3.06876409 |
| 62 | positive regulation of humoral immune response (GO:0002922) | 3.04579298 |
| 63 | positive regulation of type 2 immune response (GO:0002830) | 3.03305789 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02572788 |
| 65 | NIK/NF-kappaB signaling (GO:0038061) | 3.01697453 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.01243553 |
| 67 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00568437 |
| 68 | detection of biotic stimulus (GO:0009595) | 3.00211341 |
| 69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.00006897 |
| 70 | cellular response to interleukin-15 (GO:0071350) | 2.99440687 |
| 71 | macrophage activation (GO:0042116) | 2.98834756 |
| 72 | T-helper 1 type immune response (GO:0042088) | 2.98487459 |
| 73 | positive regulation of tolerance induction (GO:0002645) | 2.96641810 |
| 74 | B cell mediated immunity (GO:0019724) | 2.96163495 |
| 75 | regulation of response to interferon-gamma (GO:0060330) | 2.95859287 |
| 76 | response to protozoan (GO:0001562) | 2.94918233 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 2.94444774 |
| 78 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.94311724 |
| 79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91525884 |
| 80 | interferon-gamma secretion (GO:0072643) | 2.91049234 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90566564 |
| 82 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85321380 |
| 83 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.84232646 |
| 84 | negative T cell selection (GO:0043383) | 2.84179124 |
| 85 | negative thymic T cell selection (GO:0045060) | 2.82693480 |
| 86 | myeloid dendritic cell differentiation (GO:0043011) | 2.82358147 |
| 87 | regulation of natural killer cell differentiation (GO:0032823) | 2.81719019 |
| 88 | interferon-gamma production (GO:0032609) | 2.81707186 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80879821 |
| 90 | regulation of antigen processing and presentation (GO:0002577) | 2.80523366 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.80332414 |
| 92 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.80219375 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79032009 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78874677 |
| 95 | positive regulation of interleukin-12 production (GO:0032735) | 2.78314015 |
| 96 | B cell receptor signaling pathway (GO:0050853) | 2.78305852 |
| 97 | cellular response to interferon-gamma (GO:0071346) | 2.77510293 |
| 98 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.76047365 |
| 99 | natural killer cell mediated immunity (GO:0002228) | 2.76047365 |
| 100 | lymphocyte chemotaxis (GO:0048247) | 2.75516061 |
| 101 | respiratory burst (GO:0045730) | 2.74210305 |
| 102 | defense response to virus (GO:0051607) | 2.74130565 |
| 103 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73626247 |
| 104 | regulation of type 2 immune response (GO:0002828) | 2.73343970 |
| 105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.72162188 |
| 106 | neutrophil activation (GO:0042119) | 2.71960220 |
| 107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.71073930 |
| 108 | response to host immune response (GO:0052572) | 2.70060810 |
| 109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70060810 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68935349 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.68784947 |
| 112 | regulation of B cell differentiation (GO:0045577) | 2.68564300 |
| 113 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.68468266 |
| 114 | regulation of hypersensitivity (GO:0002883) | 2.68467450 |
| 115 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.67535187 |
| 116 | macrophage activation involved in immune response (GO:0002281) | 2.66510427 |
| 117 | cellular response to zinc ion (GO:0071294) | 2.66068776 |
| 118 | granulocyte activation (GO:0036230) | 2.65983015 |
| 119 | regulation of interferon-beta production (GO:0032648) | 2.65095254 |
| 120 | positive regulation of response to biotic stimulus (GO:0002833) | 2.64349249 |
| 121 | response to muramyl dipeptide (GO:0032495) | 2.64233348 |
| 122 | natural killer cell activation (GO:0030101) | 2.62949254 |
| 123 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.61091814 |
| 124 | positive regulation of defense response to virus by host (GO:0002230) | 2.58545806 |
| 125 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.57585443 |
| 126 | regulation of activation of Janus kinase activity (GO:0010533) | 2.56818971 |
| 127 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.56021274 |
| 128 | response to interferon-gamma (GO:0034341) | 2.55566949 |
| 129 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.52869180 |
| 130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.52196652 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 2.49453571 |
| 132 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.49344607 |
| 133 | leukocyte aggregation (GO:0070486) | 2.47387436 |
| 134 | cytokine secretion (GO:0050663) | 2.46018464 |
| 135 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.45802673 |
| 136 | positive regulation of B cell mediated immunity (GO:0002714) | 2.45802673 |
| 137 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.44568813 |
| 138 | response to host defenses (GO:0052200) | 2.44156240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.21943016 |
| 2 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.19822947 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.04810111 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.66278996 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.53762953 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.81148842 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.59632723 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.23281070 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.16871033 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98746506 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.95541103 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.89568818 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86767764 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85801294 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.83294567 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71040755 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51101663 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42955515 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.33725447 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.22830844 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22765302 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21237025 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19931772 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.19500866 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.11114630 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.08048115 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.02511779 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01286138 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01143294 |
| 30 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91783160 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.91156857 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90816753 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 1.89898730 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87606502 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86349726 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84699533 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80032398 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78994961 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70917631 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67234075 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60902147 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57335592 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53158220 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48767384 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48502613 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42272490 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42056823 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41025777 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40417806 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38967764 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.37431703 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32533248 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28263637 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28239377 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27244526 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26778494 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26424329 |
| 58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23434482 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20727592 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20664731 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18660606 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16775625 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16177985 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14539762 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13487190 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13417211 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10737832 |
| 68 | MAF_26560356_Chip-Seq_TH2_Human | 1.10043007 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06671190 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05714828 |
| 71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03661363 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02994669 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01913453 |
| 74 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01876423 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00789111 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00202133 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98869159 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98751470 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98449279 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97926266 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95722122 |
| 82 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94651815 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94590970 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94086526 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93359194 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91812438 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91338319 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90684968 |
| 89 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.90305146 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89439611 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89009881 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88644494 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87295382 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87101739 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86358664 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85020492 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84728403 |
| 98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83784052 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82765797 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82514397 |
| 101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81856364 |
| 102 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81735424 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81735424 |
| 104 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80778546 |
| 105 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80603279 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78521085 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78141622 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77486479 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77264460 |
| 110 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.76110254 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75886671 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75162809 |
| 113 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.73700203 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72929927 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72753753 |
| 116 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.67789013 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67557736 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62549166 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.61259803 |
| 120 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.60655916 |
| 121 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.57899167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.35619235 |
| 2 | MP0009785_altered_susceptibility_to | 3.50276330 |
| 3 | MP0000685_abnormal_immune_system | 3.06825034 |
| 4 | MP0005671_abnormal_response_to | 3.01591326 |
| 5 | MP0003436_decreased_susceptibility_to | 2.97408314 |
| 6 | MP0003724_increased_susceptibility_to | 2.80346760 |
| 7 | MP0005387_immune_system_phenotype | 2.76169009 |
| 8 | MP0001790_abnormal_immune_system | 2.76169009 |
| 9 | MP0005025_abnormal_response_to | 2.71652364 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.68441909 |
| 11 | MP0001800_abnormal_humoral_immune | 2.62615443 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.60860883 |
| 13 | MP0002419_abnormal_innate_immunity | 2.43577159 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.40121657 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.39223204 |
| 16 | MP0002723_abnormal_immune_serum | 2.36397185 |
| 17 | MP0005360_urolithiasis | 2.33139815 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.27525242 |
| 19 | MP0006082_CNS_inflammation | 2.22494499 |
| 20 | MP0001819_abnormal_immune_cell | 2.16117287 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.14315776 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.14265833 |
| 23 | MP0002006_tumorigenesis | 2.07315927 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.01230686 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.96379498 |
| 26 | MP0003303_peritoneal_inflammation | 1.86235335 |
| 27 | MP0002398_abnormal_bone_marrow | 1.81044488 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.80982313 |
| 29 | MP0004947_skin_inflammation | 1.79678826 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.79125868 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.78252246 |
| 32 | MP0000716_abnormal_immune_system | 1.76624198 |
| 33 | MP0004510_myositis | 1.75065291 |
| 34 | MP0001853_heart_inflammation | 1.75001780 |
| 35 | MP0009840_abnormal_foam_cell | 1.74969657 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.72686869 |
| 37 | MP0008469_abnormal_protein_level | 1.71688119 |
| 38 | MP0009764_decreased_sensitivity_to | 1.68822627 |
| 39 | MP0002405_respiratory_system_inflammati | 1.68571334 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.65247876 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.63519428 |
| 42 | MP0005365_abnormal_bile_salt | 1.62248463 |
| 43 | MP0005451_abnormal_body_composition | 1.58336250 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.55160016 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.51531248 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.49411292 |
| 47 | MP0001873_stomach_inflammation | 1.49191254 |
| 48 | MP0002722_abnormal_immune_system | 1.46529589 |
| 49 | MP0002429_abnormal_blood_cell | 1.45723304 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.44203188 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.44203188 |
| 52 | MP0003252_abnormal_bile_duct | 1.38562819 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.31006577 |
| 54 | MP0005164_abnormal_response_to | 1.29308839 |
| 55 | MP0004883_abnormal_blood_vessel | 1.24539072 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24130526 |
| 57 | MP0002254_reproductive_system_inflammat | 1.22110956 |
| 58 | MP0009763_increased_sensitivity_to | 1.21916368 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.21414213 |
| 60 | MP0003448_altered_tumor_morphology | 1.20280376 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.19450247 |
| 62 | MP0000609_abnormal_liver_physiology | 1.18028997 |
| 63 | MP0005310_abnormal_salivary_gland | 1.17042377 |
| 64 | MP0003045_fibrosis | 1.16251019 |
| 65 | MP0000858_altered_metastatic_potential | 1.10077977 |
| 66 | MP0003186_abnormal_redox_activity | 1.09319060 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.09313954 |
| 68 | MP0000604_amyloidosis | 1.09290821 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.09118451 |
| 70 | MP0008260_abnormal_autophagy | 1.08284835 |
| 71 | MP0009278_abnormal_bone_marrow | 1.07904757 |
| 72 | MP0003195_calcinosis | 1.05970735 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.03757570 |
| 74 | MP0000343_altered_response_to | 1.03722983 |
| 75 | MP0003866_abnormal_defecation | 1.00487119 |
| 76 | MP0003828_pulmonary_edema | 1.00028968 |
| 77 | MP0006054_spinal_hemorrhage | 0.99501182 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.95766896 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.95627691 |
| 80 | MP0003690_abnormal_glial_cell | 0.93977744 |
| 81 | MP0000490_abnormal_crypts_of | 0.93765208 |
| 82 | MP0003091_abnormal_cell_migration | 0.93417368 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.93101982 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.91722156 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.91530720 |
| 86 | MP0008004_abnormal_stomach_pH | 0.91147542 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.90279454 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.89683251 |
| 89 | MP0002933_joint_inflammation | 0.88115063 |
| 90 | MP0003075_altered_response_to | 0.83731551 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.83387626 |
| 92 | MP0000598_abnormal_liver_morphology | 0.80717705 |
| 93 | MP0004381_abnormal_hair_follicle | 0.80278877 |
| 94 | MP0001663_abnormal_digestive_system | 0.79987651 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.79752238 |
| 96 | MP0001666_abnormal_nutrient_absorption | 0.78532410 |
| 97 | MP0005083_abnormal_biliary_tract | 0.77620224 |
| 98 | MP0005390_skeleton_phenotype | 0.77417781 |
| 99 | MP0005166_decreased_susceptibility_to | 0.77390820 |
| 100 | MP0001764_abnormal_homeostasis | 0.76926802 |
| 101 | MP0010307_abnormal_tumor_latency | 0.76112854 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.75076305 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.72517130 |
| 104 | MP0003806_abnormal_nucleotide_metabolis | 0.72291100 |
| 105 | MP0000249_abnormal_blood_vessel | 0.72066677 |
| 106 | MP0002132_abnormal_respiratory_system | 0.71884233 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.71493671 |
| 108 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71273890 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.70971218 |
| 110 | MP0000371_diluted_coat_color | 0.70410659 |
| 111 | MP0009697_abnormal_copulation | 0.69750941 |
| 112 | MP0005408_hypopigmentation | 0.69591536 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.69190241 |
| 114 | MP0002019_abnormal_tumor_incidence | 0.68676481 |
| 115 | MP0003795_abnormal_bone_structure | 0.68594089 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.68014595 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.67317267 |
| 118 | MP0005023_abnormal_wound_healing | 0.66003369 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.64885170 |
| 120 | MP0000569_abnormal_digit_pigmentation | 0.64701556 |
| 121 | MP0001851_eye_inflammation | 0.63151921 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.61564702 |
| 123 | MP0005167_abnormal_blood-brain_barrier | 0.61479616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.78705602 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.59385430 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.42430161 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36685101 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.17084465 |
| 6 | Chronic otitis media (HP:0000389) | 4.13992735 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.11518281 |
| 8 | Myositis (HP:0100614) | 3.92490414 |
| 9 | Recurrent fungal infections (HP:0002841) | 3.80756085 |
| 10 | Recurrent viral infections (HP:0004429) | 3.78792454 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.43929447 |
| 12 | Vasculitis (HP:0002633) | 3.39311871 |
| 13 | Recurrent skin infections (HP:0001581) | 3.38586584 |
| 14 | Orchitis (HP:0100796) | 3.34522326 |
| 15 | Gingival bleeding (HP:0000225) | 3.32114631 |
| 16 | Joint hemorrhage (HP:0005261) | 3.31123599 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.21709845 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.14761337 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13765621 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13765621 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.12358671 |
| 22 | Abnormality of T cell number (HP:0011839) | 3.11643717 |
| 23 | Nasal polyposis (HP:0100582) | 3.10453170 |
| 24 | Periodontitis (HP:0000704) | 3.09861493 |
| 25 | Optic neuritis (HP:0100653) | 3.08347237 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.08347237 |
| 27 | Increased IgM level (HP:0003496) | 3.07899612 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.02999454 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.00409217 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98880708 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98880708 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98880708 |
| 33 | T lymphocytopenia (HP:0005403) | 2.95693721 |
| 34 | Meningitis (HP:0001287) | 2.94108146 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 2.87732088 |
| 36 | Pustule (HP:0200039) | 2.86967459 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.86775510 |
| 38 | Abnormality of T cells (HP:0002843) | 2.84854995 |
| 39 | Thrombocytosis (HP:0001894) | 2.79043108 |
| 40 | Gingivitis (HP:0000230) | 2.77800052 |
| 41 | Chest pain (HP:0100749) | 2.75542393 |
| 42 | Epistaxis (HP:0000421) | 2.75261719 |
| 43 | Autoimmune hemolytic anemia (HP:0001890) | 2.73806480 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.72909104 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.72033670 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.69730641 |
| 47 | Myocardial infarction (HP:0001658) | 2.67863156 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.63011891 |
| 49 | Eosinophilia (HP:0001880) | 2.62161641 |
| 50 | Basal ganglia calcification (HP:0002135) | 2.61361263 |
| 51 | IgM deficiency (HP:0002850) | 2.59338060 |
| 52 | Hemoptysis (HP:0002105) | 2.57797902 |
| 53 | Stomatitis (HP:0010280) | 2.56431711 |
| 54 | Cellulitis (HP:0100658) | 2.56127294 |
| 55 | Gangrene (HP:0100758) | 2.54482219 |
| 56 | Arterial thrombosis (HP:0004420) | 2.53128973 |
| 57 | Chronic diarrhea (HP:0002028) | 2.52395684 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.52334470 |
| 59 | Petechiae (HP:0000967) | 2.51287167 |
| 60 | Leukocytosis (HP:0001974) | 2.48937998 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.48215525 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.47668596 |
| 63 | Prolonged bleeding time (HP:0003010) | 2.47283327 |
| 64 | Loss of speech (HP:0002371) | 2.46735816 |
| 65 | Colitis (HP:0002583) | 2.45873290 |
| 66 | Obstructive lung disease (HP:0006536) | 2.44555541 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44555541 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.43514260 |
| 69 | Granulocytopenia (HP:0001913) | 2.43197253 |
| 70 | Peritonitis (HP:0002586) | 2.42187632 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.42076014 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.41569773 |
| 73 | Encephalitis (HP:0002383) | 2.41358901 |
| 74 | Joint swelling (HP:0001386) | 2.40754967 |
| 75 | Complement deficiency (HP:0004431) | 2.38809330 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.38641736 |
| 77 | Gastrointestinal inflammation (HP:0004386) | 2.36181348 |
| 78 | Cheilitis (HP:0100825) | 2.35505442 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.33508030 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.33313721 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.31611062 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 2.31160265 |
| 83 | Increased IgE level (HP:0003212) | 2.30566076 |
| 84 | IgG deficiency (HP:0004315) | 2.30421684 |
| 85 | Abnormality of eosinophils (HP:0001879) | 2.28904263 |
| 86 | Deep venous thrombosis (HP:0002625) | 2.26855980 |
| 87 | Malnutrition (HP:0004395) | 2.26204593 |
| 88 | Lymphopenia (HP:0001888) | 2.24604060 |
| 89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23508176 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.21836109 |
| 91 | Pulmonary embolism (HP:0002204) | 2.20962856 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.19680067 |
| 93 | Hematochezia (HP:0002573) | 2.19491563 |
| 94 | Abnormal platelet volume (HP:0011876) | 2.19177533 |
| 95 | Osteomyelitis (HP:0002754) | 2.19123164 |
| 96 | Chronic sinusitis (HP:0011109) | 2.18438521 |
| 97 | Anorexia (HP:0002039) | 2.17665543 |
| 98 | Glomerulonephritis (HP:0000099) | 2.17657427 |
| 99 | Episodic fever (HP:0001954) | 2.17227370 |
| 100 | IgA deficiency (HP:0002720) | 2.15299126 |
| 101 | Purpura (HP:0000979) | 2.14753278 |
| 102 | Keratoconjunctivitis (HP:0001096) | 2.14391323 |
| 103 | Combined immunodeficiency (HP:0005387) | 2.13068488 |
| 104 | Urticaria (HP:0001025) | 2.12706359 |
| 105 | Abnormality of the pericardium (HP:0001697) | 2.11691753 |
| 106 | Severe combined immunodeficiency (HP:0004430) | 2.11426319 |
| 107 | Thyroiditis (HP:0100646) | 2.11229882 |
| 108 | Thrombophlebitis (HP:0004418) | 2.11225857 |
| 109 | Abnormality of the endocardium (HP:0004306) | 2.11058664 |
| 110 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.10279820 |
| 111 | Amyloidosis (HP:0011034) | 2.10166778 |
| 112 | Xanthomatosis (HP:0000991) | 2.09658569 |
| 113 | Hypobetalipoproteinemia (HP:0003563) | 2.08574712 |
| 114 | Menorrhagia (HP:0000132) | 2.08458363 |
| 115 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.06458859 |
| 116 | Esophageal varix (HP:0002040) | 2.05948634 |
| 117 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05821243 |
| 118 | Gastrointestinal stroma tumor (HP:0100723) | 2.03128452 |
| 119 | Increased serum ferritin (HP:0003281) | 1.99475538 |
| 120 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99387520 |
| 121 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99387520 |
| 122 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99387520 |
| 123 | Glomerulopathy (HP:0100820) | 1.98585428 |
| 124 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.96082948 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.96007271 |
| 126 | Alveolar cell carcinoma (HP:0006519) | 1.94744518 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93178911 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.93178911 |
| 129 | Acne (HP:0001061) | 1.93041072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 3.87700488 |
| 2 | MAP3K14 | 3.78278173 |
| 3 | MAP4K1 | 3.44710251 |
| 4 | JAK3 | 3.27264109 |
| 5 | IKBKE | 3.20582896 |
| 6 | TBK1 | 3.03519741 |
| 7 | TXK | 2.95490218 |
| 8 | FGFR4 | 2.90078439 |
| 9 | KIT | 2.69145513 |
| 10 | IRAK4 | 2.66092407 |
| 11 | JAK1 | 2.54551019 |
| 12 | BLK | 2.05861607 |
| 13 | IRAK3 | 2.05738622 |
| 14 | ERN1 | 2.03396003 |
| 15 | IKBKB | 2.01912318 |
| 16 | FGFR3 | 1.88521250 |
| 17 | TAOK3 | 1.84555234 |
| 18 | PRPF4B | 1.77925479 |
| 19 | ZAP70 | 1.77258665 |
| 20 | TEC | 1.67812034 |
| 21 | MAP3K13 | 1.66314167 |
| 22 | BTK | 1.65165919 |
| 23 | FLT3 | 1.60343094 |
| 24 | NLK | 1.59883753 |
| 25 | SYK | 1.49822640 |
| 26 | RIPK4 | 1.45434858 |
| 27 | CHUK | 1.43625448 |
| 28 | GRK7 | 1.41533360 |
| 29 | CSF1R | 1.35627224 |
| 30 | CSK | 1.34997773 |
| 31 | NEK9 | 1.34381365 |
| 32 | EPHA3 | 1.34028890 |
| 33 | PIM1 | 1.33034524 |
| 34 | STK10 | 1.29402938 |
| 35 | ITK | 1.27847588 |
| 36 | NME2 | 1.27132658 |
| 37 | FGR | 1.26976931 |
| 38 | LCK | 1.26933666 |
| 39 | TGFBR2 | 1.21609782 |
| 40 | JAK2 | 1.20291554 |
| 41 | HCK | 1.18699378 |
| 42 | PIM2 | 1.18670564 |
| 43 | EPHB1 | 1.14059451 |
| 44 | RPS6KA4 | 1.13497211 |
| 45 | PBK | 1.11871865 |
| 46 | MST4 | 1.10752535 |
| 47 | MAP3K1 | 1.08696181 |
| 48 | GRK6 | 1.06119432 |
| 49 | CDC42BPA | 1.05137634 |
| 50 | TAOK1 | 1.01439281 |
| 51 | LYN | 0.98881364 |
| 52 | MAP3K2 | 0.94425250 |
| 53 | STK4 | 0.92455058 |
| 54 | MAP2K3 | 0.91881713 |
| 55 | IRAK1 | 0.88528686 |
| 56 | EIF2AK2 | 0.87391671 |
| 57 | NUAK1 | 0.87184553 |
| 58 | SIK1 | 0.85674911 |
| 59 | KDR | 0.85175673 |
| 60 | MAP3K10 | 0.84455124 |
| 61 | MAPK11 | 0.78295911 |
| 62 | CAMKK2 | 0.76859815 |
| 63 | MATK | 0.75487294 |
| 64 | TRPM7 | 0.74543918 |
| 65 | PKN2 | 0.69967394 |
| 66 | MARK3 | 0.68994959 |
| 67 | PDK1 | 0.68597840 |
| 68 | ACVR1B | 0.68374095 |
| 69 | TAOK2 | 0.66463035 |
| 70 | YES1 | 0.64803368 |
| 71 | PRKCQ | 0.62341152 |
| 72 | IRAK2 | 0.61013594 |
| 73 | LRRK2 | 0.60612716 |
| 74 | PTK6 | 0.60458515 |
| 75 | MAP2K6 | 0.59574085 |
| 76 | MAP3K11 | 0.59304060 |
| 77 | MST1R | 0.59123505 |
| 78 | CDK6 | 0.58511077 |
| 79 | FRK | 0.58003852 |
| 80 | RIPK1 | 0.56217269 |
| 81 | SIK3 | 0.55722300 |
| 82 | PDPK1 | 0.54436531 |
| 83 | MAPK7 | 0.54229585 |
| 84 | PIK3CG | 0.54121036 |
| 85 | CDK4 | 0.52491608 |
| 86 | PRKD2 | 0.50457394 |
| 87 | EEF2K | 0.50239081 |
| 88 | CLK1 | 0.50005748 |
| 89 | FES | 0.49663996 |
| 90 | DDR2 | 0.48929329 |
| 91 | TGFBR1 | 0.48497232 |
| 92 | PTK2B | 0.46690374 |
| 93 | ABL1 | 0.46100332 |
| 94 | TRIB3 | 0.45235501 |
| 95 | MELK | 0.44576570 |
| 96 | BMPR2 | 0.42622501 |
| 97 | MAPK4 | 0.41887193 |
| 98 | FER | 0.41293631 |
| 99 | CDK12 | 0.41181492 |
| 100 | PRKCD | 0.40668954 |
| 101 | PDGFRB | 0.39779174 |
| 102 | RPS6KA5 | 0.38905539 |
| 103 | FYN | 0.38810732 |
| 104 | STK3 | 0.38781301 |
| 105 | BCKDK | 0.37695879 |
| 106 | EGFR | 0.37670070 |
| 107 | MAP3K5 | 0.37055761 |
| 108 | HIPK2 | 0.36800631 |
| 109 | MAP3K3 | 0.36348440 |
| 110 | SGK3 | 0.31476791 |
| 111 | RPS6KA6 | 0.30273506 |
| 112 | MARK2 | 0.29755413 |
| 113 | DYRK1B | 0.29566396 |
| 114 | KSR2 | 0.29484903 |
| 115 | EIF2AK1 | 0.29231509 |
| 116 | SMG1 | 0.28921602 |
| 117 | ABL2 | 0.28456891 |
| 118 | MAPK3 | 0.28118983 |
| 119 | ADRBK2 | 0.27674110 |
| 120 | STK38 | 0.27596304 |
| 121 | IGF1R | 0.27498698 |
| 122 | PRKAA2 | 0.27273191 |
| 123 | WNK1 | 0.27270201 |
| 124 | CAMK1D | 0.26677711 |
| 125 | TNK2 | 0.26231610 |
| 126 | MAP2K2 | 0.26133142 |
| 127 | STK24 | 0.25788848 |
| 128 | TIE1 | 0.25131857 |
| 129 | MAPKAPK2 | 0.25075389 |
| 130 | MAP3K7 | 0.24944740 |
| 131 | SIK2 | 0.22608213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.87605074 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.62703825 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62272755 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.60303886 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.54328243 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.51473440 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.49998570 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.48570089 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.44223166 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.30441718 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20093686 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18239486 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02897834 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00837873 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.91839880 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.83491907 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78702879 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75873749 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73997899 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.73560254 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.70368830 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56676248 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.55978378 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.50642024 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48024169 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47840080 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45083924 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.43800480 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43797840 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39733616 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35427076 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.34803795 |
| 33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26432882 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25864121 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.24548885 |
| 36 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.23204609 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16158666 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.14511296 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.13040885 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11550865 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.10421510 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.08912272 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.07872944 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07618668 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05817143 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.03547153 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97608970 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93645933 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89506850 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.88482089 |
| 51 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87280028 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87262702 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86777665 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.83941253 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.80475843 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77723747 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76578461 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.76062471 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74205248 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71833091 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71759458 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71729096 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71286520 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70262937 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68661530 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68541894 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66248889 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66180425 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64904264 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64816011 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62088026 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61050638 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60547416 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58643362 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58595884 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58542125 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58151301 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58018795 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.57890873 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57777467 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56686911 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56232429 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54976592 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54356291 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54220916 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53826692 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.53698899 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.53495120 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51767947 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50719062 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48388793 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48336683 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47361956 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47171526 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45634997 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45463354 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45046238 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44950270 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43927422 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.43599010 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43346811 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43093477 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42116398 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42010263 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.41754564 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38949092 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38610153 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38259853 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36935824 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36763598 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35799639 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35789874 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35471599 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34718030 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.33564038 |
| 116 | Endocytosis_Homo sapiens_hsa04144 | 0.32561492 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31770303 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.31239764 |
| 119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30565710 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28750916 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28349887 |
| 122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25730745 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.25364577 |
| 124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25158938 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24646924 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.24041999 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23017036 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22394563 |
| 129 | Bladder cancer_Homo sapiens_hsa05219 | 0.21867118 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20111516 |

